MONTREAL – Analysis of circulating human papillomavirus (HPV) tumor DNA and tumor DNA fragment (tumor tissue–modified viral ([TTMV])-HPV DNA using a commercially available blood test – a so-called ...

HealthDay News — Combining human papillomavirus (HPV) DNA testing with cytology testing at first screening resulted in fewer cases of high-grade cervical intraepithelial neoplasia (CIN) lesions and ...

The Ministry of Health reported that DNA testing for human papillomavirus (HPV) with a high oncogenic risk is included in the ...

Rice University bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where ...

Spatial genomics to reveal an immunosuppressive tumor microenvironment after chemoradiation in head and neck cancer patients. #Surveillance cohort analysis performed at the test level; individual ...

The addition of human papillomavirus (HPV) DNA testing to either conventional or liquid-based cytology has previously been shown to increase detection rates of high-grade cervical intraepithelial ...

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear. This is the discovery of Mass General Brigham researchers who ...

Scientists at Mass General Brigham have created HPV-DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, ...

PHOENIX — A liquid biopsy test may accurately predict recurrence of human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma (OPSCC) earlier than standard clinical and imaging ...

Please provide your email address to receive an email when new articles are posted on . A blood test to detect circulating tumor DNA accurately predicted recurrence of HPV-driven oropharyngeal cancer ...

Ari Rosenberg, an oncologist at the University of Chicago Medicine, has been trying to improve conditions for people being treated for oropharyngeal squamous cell carcinoma (OPSCC). Incidence of these ...